NR565 Week 8 Final Exam Due October
25th 2025 Complete 100 Actual Exam
Questions and Answers Examplify Online
Proctored Exam NR565 Advanced
Pharmacology Fundamentals | 100% Pass
Guaranteed | Graded A+ |
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
(Questions 1-15)
Question 1
A drug has a half-life of 24 hours. Approximately how long will it take for the drug
to reach steady state?
A) 24 hours
B) 48 hours
C) 5 days
D) 10 days
Correct ,,,ANSWER,,,: C
,Rationale: Steady state is achieved after approximately 4-5 half-lives. For a drug
with a 24-hour half-life, steady state is reached in about 5 days (120 hours) .
Question 2
A patient is receiving a drug that follows first-order elimination kinetics. Which
statement best describes this process?
A) A constant amount of drug is eliminated per unit time
B) A constant percentage of drug is eliminated per unit time
C) Elimination is saturable at therapeutic doses
D) The half-life increases with dose
Correct ,,,ANSWER,,,: B
Rationale: First-order kinetics means a constant fraction (percentage) of the drug
is eliminated per unit time. Zero-order kinetics eliminates a constant amount per
unit time (e.g., phenytoin, ethanol) .
Question 3
Which pharmacokinetic process is most affected by first-pass metabolism?
A) Intravenous distribution
B) Protein binding
C) Oral absorption
D) Renal excretion
Correct ,,,ANSWER,,,: C
,Rationale: First-pass metabolism occurs in the liver and gut wall after oral
administration, reducing the amount of active drug reaching systemic circulation.
Drugs with extensive first-pass effect often require higher oral doses or alternative
routes .
Question 4
Which cytochrome P450 enzyme is responsible for metabolizing approximately
50% of all marketed drugs?
A) CYP2D6
B) CYP2C9
C) CYP3A4
D) CYP1A2
Correct ,,,ANSWER,,,: C
Rationale: CYP3A4 is the most abundant hepatic and intestinal CYP enzyme,
involved in the metabolism of many drugs, including statins, calcium channel
blockers, and immunosuppressants .
Question 5
A patient with end-stage renal disease requires a drug that is primarily renally
excreted. What adjustment is typically required?
A) Increase the dose
B) Reduce the dose or increase the dosing interval
, C) No adjustment is needed
D) Change to intravenous administration
Correct ,,,ANSWER,,,: B
Rationale: When creatinine clearance is reduced, drug accumulation occurs. Dose
adjustment based on estimated GFR maintains therapeutic levels without toxicity .
Question 6
What is the clinical significance of the therapeutic index (TI)?
A) It indicates the drug's half-life
B) It measures protein binding affinity
C) A narrow TI indicates a small margin between therapeutic and toxic doses
D) It predicts drug-drug interactions
Correct ,,,ANSWER,,,: C
Rationale: Drugs with narrow TI (e.g., warfarin, digoxin, phenytoin) require
careful monitoring of serum levels to avoid toxicity while ensuring efficacy .
Question 7
What is bioavailability?
A) The rate at which drug is metabolized
B) The amount of drug that reaches systemic circulation unchanged
25th 2025 Complete 100 Actual Exam
Questions and Answers Examplify Online
Proctored Exam NR565 Advanced
Pharmacology Fundamentals | 100% Pass
Guaranteed | Graded A+ |
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
(Questions 1-15)
Question 1
A drug has a half-life of 24 hours. Approximately how long will it take for the drug
to reach steady state?
A) 24 hours
B) 48 hours
C) 5 days
D) 10 days
Correct ,,,ANSWER,,,: C
,Rationale: Steady state is achieved after approximately 4-5 half-lives. For a drug
with a 24-hour half-life, steady state is reached in about 5 days (120 hours) .
Question 2
A patient is receiving a drug that follows first-order elimination kinetics. Which
statement best describes this process?
A) A constant amount of drug is eliminated per unit time
B) A constant percentage of drug is eliminated per unit time
C) Elimination is saturable at therapeutic doses
D) The half-life increases with dose
Correct ,,,ANSWER,,,: B
Rationale: First-order kinetics means a constant fraction (percentage) of the drug
is eliminated per unit time. Zero-order kinetics eliminates a constant amount per
unit time (e.g., phenytoin, ethanol) .
Question 3
Which pharmacokinetic process is most affected by first-pass metabolism?
A) Intravenous distribution
B) Protein binding
C) Oral absorption
D) Renal excretion
Correct ,,,ANSWER,,,: C
,Rationale: First-pass metabolism occurs in the liver and gut wall after oral
administration, reducing the amount of active drug reaching systemic circulation.
Drugs with extensive first-pass effect often require higher oral doses or alternative
routes .
Question 4
Which cytochrome P450 enzyme is responsible for metabolizing approximately
50% of all marketed drugs?
A) CYP2D6
B) CYP2C9
C) CYP3A4
D) CYP1A2
Correct ,,,ANSWER,,,: C
Rationale: CYP3A4 is the most abundant hepatic and intestinal CYP enzyme,
involved in the metabolism of many drugs, including statins, calcium channel
blockers, and immunosuppressants .
Question 5
A patient with end-stage renal disease requires a drug that is primarily renally
excreted. What adjustment is typically required?
A) Increase the dose
B) Reduce the dose or increase the dosing interval
, C) No adjustment is needed
D) Change to intravenous administration
Correct ,,,ANSWER,,,: B
Rationale: When creatinine clearance is reduced, drug accumulation occurs. Dose
adjustment based on estimated GFR maintains therapeutic levels without toxicity .
Question 6
What is the clinical significance of the therapeutic index (TI)?
A) It indicates the drug's half-life
B) It measures protein binding affinity
C) A narrow TI indicates a small margin between therapeutic and toxic doses
D) It predicts drug-drug interactions
Correct ,,,ANSWER,,,: C
Rationale: Drugs with narrow TI (e.g., warfarin, digoxin, phenytoin) require
careful monitoring of serum levels to avoid toxicity while ensuring efficacy .
Question 7
What is bioavailability?
A) The rate at which drug is metabolized
B) The amount of drug that reaches systemic circulation unchanged
